Zenas BioPharma CEO Purchases 60,000 Shares in Open-Market Transaction
Leon O. Molder Jr., CEO of Zenas BioPharma (NASDAQ: ZBIO), purchased 60,000 shares at a weighted average price of $16.88 per share through an open-market transaction. The purchase aligns with his historical accumulation pattern and increases his direct ownership to approximately 423,155 shares.
Tickers: $ZBIO
Topics: insider buying SEC filing Zenas BioPharma